Take one Montica 5 mg chewable tablet once daily in the evening. The tablet should be chewed thoroughly before swallowing. It can be taken with or without food.

Montelukast selectively blocks the cysteinyl leukotriene Type 1 (CysLT1) receptor, preventing the actions of leukotrienes (LTC4, LTD4, LTE4). This reduces bronchoconstriction, inflammation, and mucus secretion, improving asthma and allergic rhinitis symptoms.

• •Hypersensitivity to montelukast or any component of the formulation.
• •Not indicated for the treatment of acute asthma attacks (including status asthmaticus).

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

In cases of overdose, symptoms such as abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity have been reported. Management is supportive and symptomatic.

Pregnancy Category B. Use only if clearly needed. It is unknown whether montelukast is excreted in human milk; caution should be exercised when administered to a nursing mother.